Stock market announcement archive

Lifecare ASA: Mandatory notification of trade by primary insiders and close associates

May 30, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Please see the attached PDMR-forms related to allocation of subscription rights to primary insiders and close associates of primary insiders in […]
Read more

LIFE – Lifecare CEO presents at Redeye Growth Day 2024

May 30, 2024
Bergen, Norway, 30 May 2024: Today, at 13:00 CEST Lifecare CEO Joacim Holter will participate at Redeye Growth Day 2024 and present the latest development of the company. ****** Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the […]
Read more

Lifecare ASA: Commencement of the subscription period for the Rights Issue and start of trading in Subscription Rights

May 30, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more

Lifecare ASA: FAQ regarding Rights Issue

May 29, 2024
Reference is made to the previous stock exchange announcements published by Lifecare ASA (“Lifecare” or the “Company”) regarding the partially underwritten rights issue. Frequently asked questions (FAQ) on the Rights Issue is avalaible in the attachment. About usLifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body […]
Read more

Lifecare ASA: Registration of national prospectus for the preferential Rights Issue

May 29, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF […]
Read more

LIFE – Ex. Subscription Rights today

May 21, 2024
Issuer: Lifecare ASAEx. date: 21 May 2024 Type of corporate action: Preferential rights issueOther information: The shares in Lifecare ASA will from today, 21 May 2024, be traded exclusive of the right to receive subscription rights for shares in the preferential rights issue announced on 25 April 2024.             This information is published in accordance with the requirements […]
Read more

Minutes from Extraordinary General Meeting

May 16, 2024
The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 16 May 2024. All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 2. May 2024. The complete minutes of the Extraordinary General Meeting are attached and will […]
Read more

Lifecare ASA: Updated key information relating to the preferential rights issue

May 15, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement published […]
Read more

LIFE – Conversion to a public limited liability company registered

May 13, 2024
Bergen, Norway, 29 April 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that its conversion to a public limited liability company has been registered. Lifecare ASA’s conversion to a public limited liability company and corresponding name change from Lifecare AS to Lifecare ASA […]
Read more

Lifecare Q1 2024 Report – From preparations phase to pilot production

May 8, 2024
Bergen, Norway, May 5th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q1 financial report and operational update. Lifecare Q1 report 2024 is available here Lifecare has been delivering milestones on a continuous basis over a long period. The company has […]
Read more